These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15172050)

  • 1. Interleukin-18 and the treatment of rheumatoid arthritis.
    Dinarello CA
    Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with inhibition of interleukin-6.
    Choy E
    Rheum Dis Clin North Am; 2004 May; 30(2):405-15, viii. PubMed ID: 15172049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin-18 and new drugs. Protective effect against tumor growth and infections].
    Wollheim FA
    Lakartidningen; 2000 Oct; 97(41):4604. PubMed ID: 11107747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-18 and the pathogenesis of inflammatory diseases.
    Dinarello CA
    Semin Nephrol; 2007 Jan; 27(1):98-114. PubMed ID: 17336692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18: a therapeutic target in rheumatoid arthritis?
    McInnes IB; Liew FY; Gracie JA
    Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
    Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
    Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting IL-17 and Th17 cells in rheumatoid arthritis.
    Sarkar S; Fox DA
    Rheum Dis Clin North Am; 2010 May; 36(2):345-66. PubMed ID: 20510238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine networks--towards new therapies for rheumatoid arthritis.
    McInnes IB; Liew FY
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
    Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
    Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
    Furst DE
    Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO; Paleolog E; Feldmann M
    Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
    Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
    Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
    Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.
    Rooney T; Murphy E; Benito M; Roux-Lombard P; FitzGerald O; Dayer JM; Bresnihan B
    Ann Rheum Dis; 2004 Nov; 63(11):1393-8. PubMed ID: 15479888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological agents targeting interleukin-18.
    Jelusic M; Lukic IK; Batinic D
    Drug News Perspect; 2007 Oct; 20(8):485-94. PubMed ID: 18080035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
    Jacques C; Gosset M; Berenbaum F; Gabay C
    Vitam Horm; 2006; 74():371-403. PubMed ID: 17027524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Horai R; Nakajima A; Habiro K; Kotani M; Nakae S; Matsuki T; Nambu A; Saijo S; Kotaki H; Sudo K; Okahara A; Tanioka H; Ikuse T; Ishii N; Schwartzberg PL; Abe R; Iwakura Y
    J Clin Invest; 2004 Dec; 114(11):1603-11. PubMed ID: 15578092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.